Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 584 of 6351
-
Surgical glue may seal pancreas after cancer surgery, cutting dangerous leaks
Disease control Recruiting nowThis is a single-center, randomized controlled trial comparing the efficacy of pancreaticojejunostomy with modified N-butyl-2-cyanoacrylate(Glubran® 2) versus standard pancreaticojejunostomy without cyanoacrylate in preventing postoperative pancreatic fistula (POPF) in patients u…
Phase 3 • Sponsor: Minia University • Aim: Disease control
Last updated Jun 26, 2026 18:42 UTC
-
Promising combo targets tough leukemia in vulnerable patients
Disease control Recruiting nowThe goal of this clinical trial is to learn if a treatment combination-venetoclax plus hypomethylating agents (like azacitidine or decitabine) and low-dose cytarabine-works to treat adults with newly diagnosed CEBPA-mutated acute myeloid leukemia (AML) who can't tolerate intensiv…
Phase 1/2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope for tough nasopharyngeal cancer: Triple-Drug combo trial launches
Disease control Recruiting nowThis is a prospective, single-arm Phase 2 study to evaluate the efficacy and safety of sintilimab combined with anlotinib and taxane-based chemotherapy in patients with recurrent (not unable to locally curative treatment) or metastatic NPC who failed at least first-line platinum-…
Phase 2 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New pill may boost vision in wet AMD patients
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of SMZ1 tablets in combination with Ranibizumab compared with placebo in combination with Ranibizumab in subjects with neovascular (wet) age-related macular degeneration (nAMD) without polypoidal choroidal vasculopa…
Phase 3 • Sponsor: SANGMYUNG innovation • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Surgery vs. glue: which seals the deal for anal fistulas?
Disease control Recruiting nowThis study aims to compare ligation of the intersphincteric fistula tract with cyanoacrylate glue in the management of high transsphincteric perianal fistula.
Sponsor: Ain Shams University • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can sensory training boost balance in down syndrome?
Disease control Recruiting nowTo investigate the effect of sensory integration on gross motor function in children with Down syndrome. To investigate the effect of sensory integration on balance in children with Down syndrome.
Sponsor: Raheel Sanad • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Could a 20% lower anesthetic dose make C-Sections safer?
Disease control Recruiting nowEffect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.
Phase 4 • Sponsor: Aswan University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
AI-Powered tool could spot autism in toddlers earlier than ever
Diagnosis Not yet recruitingThe goal of this observational study is to assess the effectiveness of a machine-assisted system for early screening of autism. The main questions it aims to answer are: * Does the machine-assisted system including 5 main behavioral paradigms identify toddlers with autism from t…
Sponsor: Children's Hospital of Fudan University • Aim: Diagnosis
Last updated Jun 26, 2026 18:11 UTC
-
Could a cholesterol drug boost stroke recovery?
Disease control Not yet recruitingThis is a prospective, multicenter, randomized controlled clinical study to evaluate the efficacy of PCSK9 inhibitor in addition to standard therapy in patients with acute ischemic stroke undergoing endovascular therapy.
Phase 2/3 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 26, 2026 17:12 UTC
-
Chilled magnesium may boost stroke recovery in new trial
Disease control By invitation onlyThe primary objective of this study is to estimate the safety and effectiveness of selective intra-arterial hypothermic magnesium sulfate infusion after endovascular thrombectomy in patients with acute ischemic stroke. Addendum regarding phase 1 dosing implementation and planned…
Phase 1/2 • Sponsor: Capital Medical University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New risk score could tailor therapy for aggressive myeloma
Disease control Not yet recruitingThis real-world, multicenter prospective clinical study is designed to apply our internationally developed prognostic scoring system to guide individualized therapy in +1q newly diagnosed multiple myeloma (NDMM), using minimal residual disease (MRD) status as the primary endpoint…
Sponsor: FengYan Jin • Aim: Disease control
Last updated Jun 26, 2026 17:11 UTC
-
New hope for Hard-to-Treat depression in seniors: esketamine spray vs aripiprazole
Symptom relief Not yet recruitingPhase III, open label, randomised, multicentre, blind for evaluators clinical trial to evaluate the efficacy of esketamine nasal spray at flexible dosis compared to aripiprazole in elderly participants (\>60 years) who suffer from treatment-resistant major depressive
Phase 3 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Symptom relief
Last updated Jun 26, 2026 13:33 UTC
-
New mRNA vaccine aims to shield older adults from RSV
Vaccine OngoingThe primary objective of this study is to evaluate the immunogenicity and safety of a single injection of two dose levels of ABO1105 in adults aged 50 years or above.
Phase 2 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: Vaccine
Last updated Jun 27, 2026 08:04 UTC
-
New adaptive chemo strategy aims to outsmart advanced breast cancer
Disease control Recruiting nowThe primary objective of this study is to explore the efficacy and safety of adaptive therapy in the treatment of advanced breast cancer progressive after standard treatment.
Phase 3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Can targeted exercises and nerve stretching restore a symmetrical smile?
Symptom relief Recruiting nowBell's palsy is an acute,unilateral facial paresis that significantly affects patient's facial symmetry,motor function and quality of life.The primary goal of this randomized controlled trial is to determine if integrating the targeted neural mobilization with proprioceptive neur…
Sponsor: Foundation University Islamabad • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
New drug aims to halt lung damage in autoimmune patients
Disease control Recruiting nowAdults 18 years of age and older or above legal age with lung fibrosis related to systemic autoimmune rheumatic disease can participate in this study. People can only take part if they show no improvement in lung function after standard treatment with immunosuppressant medicine. …
Phase 3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could heading the ball leave lasting marks on Women's brains?
Knowledge-focused Recruiting nowThe objective of this study is to evaluate, using MRI, the microstructural consequences and the onset of any cognitive impairment in female professional soccer players at the end of their career, who have experienced repeated minor head injuries. Over the long term, these head in…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Heart transplant patients may get safer virus protection
Disease control Recruiting nowThe purpose of this study is to compare the safety and efficacy of letermovir with valganciclovir for prevention of Cytomegalovirus (CMV) viremia in moderate to high risk serostatus heart transplant recipients.
Phase 2/3 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug combo targets tough blood cancers
Disease control Recruiting nowTo learn about the safety and tolerability of study drug combinations in patients with relapsed/refractory, IDH1-mutated myeloid malignancies with a co-signaling mutation.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New hope for GBS: Single-Dose drug enters final testing
Disease control Recruiting nowThe goal of this open label study is to measure pharmacokinetics, pharmacodynamics, early efficacy, and safety of tanruprubart in adult and pediatric participants, in the United States, Canada, and Europe.
Phase 3 • Sponsor: Annexon, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC